---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000484"
form_type: "8-K"
ticker: "BRGX"
cik: "0001593184"
company_name: "BIOREGENX, INC."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T19:30:59.319872+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Robert Doran resigns from BioRegenx board effective Jan 31, 2025

## Summary
- Robert Doran submitted resignation as director on Jan 15, effective Jan 31, 2025.
- No reason for departure provided in the filing.
- No replacement director was named; board composition will change.

## SEC filing metadata
- accession: 0001683168-25-000484
- form_type: 8-K
- ticker: BRGX
- cik: 0001593184
- company_name: BIOREGENX, INC.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593184/000168316825000484/0001683168-25-000484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593184/000168316825000484/bioregenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000484
- JSON: https://secwatch.observer/filing/0001683168-25-000484.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000484.txt

## Key facts
- Executive change
  Robert Doran resigned as director at BIOREGENX, INC..
  - Action: resigned
  - Role: director
  source text: On January 15, 2025, Robert Doran submitted his resignation from his position as director of BioRegenx, Inc., which shall be effective January 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316825000484/0001683168-25-000484-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.